StockPriceToday
Palo Alto Networks Inc (PANW)
About Palo Alto Networks Inc
Palo Alto Networks Inc. provides comprehensive cybersecurity platform solutions that protect organizations from cyber threats across network, cloud, and endpoint environments. The company's platform approach to cybersecurity has made PANW stock price sensitive to enterprise security spending and evolving threat landscapes.
Palo Alto Networks' next-generation firewalls and security platform provide advanced threat prevention, detection, and response capabilities for organizations of all sizes. The company's solutions integrate artificial intelligence and machine learning to identify and block sophisticated cyber attacks.
The company's cloud security offerings protect applications and data in public cloud environments while its endpoint protection solutions secure devices and user access. Palo Alto Networks' subscription services generate recurring revenue while providing ongoing threat intelligence and security updates, influencing PANW stock price performance.
Palo Alto Networks' expansion into security orchestration, automation, and response demonstrates its commitment to helping organizations manage complex security operations efficiently. The company's ability to innovate and maintain technology leadership while scaling globally remains important for its continued growth and market positioning.
PANW Stock 12 Month Chart
Latest News for PANW
The stock has fallen 20% from its Oct. 6 high, but is still up nearly 80% in 2026 as demand for cybersecurity solutions grows.
Palo Alto Networks (PANW) stock rose 10% after a Q1 beat, a higher FY27 outlook and a $4.5B Applied Compute deal. See the numbers and analyst targets.
Here are some of the stocks making notable moves in Thursday's premarket action: Palo Alto Networks shares are jumping more than 9% after the cybersecurity group [posted well-received earnings]( ...
Other Popular Stocks
First Community Bankshares Inc. (FCBC) is a bank holding company that operates First Community Bank, providing commercial and consumer banking services in Virginia, West...
Precigen Inc. (PGEN) is a biotechnology company developing innovative gene and cell therapies using its proprietary platforms to create treatments for cancer, autoimmune disorders,...
Apellis Pharmaceuticals Inc. is a biotechnology company developing complement pathway therapies for rare diseases and other serious conditions.